entertainment -WSS

entertainment

author：entertainment 2025-10-01 23:02:50 - browse：7556

A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Medicare Advantage enrollment hits roughly 33.4 million

focus

Wikipedia

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

In 'major milestone,' FDA approves first cell therapy for solid tumors

NEJM study link tiny plastics in blood vessels to heart problems

Just how do doctors, lawmakers, and the public define abortion?

Amylyx ALS drug failure raises questions and concerns

hotspot

entertainment

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Reporting on presidential health from Reagan to Trump and Biden

Trump demands the U.S. pay no more for drugs than other countries … again

RSV shot was 90% effective at preventing hospitalizations in kids

Wildfire smoke exposes gaps in outdoor worker protections

Novo Nordisk obesity pill bests Wegovy in early trial

23andMe had bad news about my health. I wish a person had delivered it

In his State of the Union, Biden takes clear aim at 'Big Pharma'

State Dept. review finds Biden bears some blame for Afghanistan failures

NEJM study link tiny plastics in blood vessels to heart problems

focus

Novo Nordisk obesity pill bests Wegovy in early trial

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

RSV shot was 90% effective at preventing hospitalizations in kids

Hospitals are piloting generative AI tools as regulators play catch

Weight loss drugs aren’t covered by Obamacare. That may change

focus

hotspot

Wikipedia

focus